MicroRNAs - new biomarkers of respiratory tract diseases;MicroRNAs - nowe biomarkery chorób dróg oddechowych

Pneumonologia i Alergologia Polska

Volumn 82, Issue 2, 2014, Pages 183-190

  Kupczyk, Maciej ^a   Kuna, Piotr ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Biomarkers; Bronchial asthma; Epigenetics; Lung cancer; MicroRNA

Indexed keywords

CYTOKINE; GENETIC MARKER; IL10 PROTEIN, HUMAN; INTERLEUKIN 10; INTERLEUKIN 12; MICRORNA; TUMOR MARKER;

ANIMAL; ASTHMA; CARCINOMA, NON-SMALL-CELL LUNG; GENE EXPRESSION REGULATION; GENETIC MARKER; GENETICS; HUMAN; LUNG NEOPLASMS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY TRACT DISEASES; SARCOIDOSIS, PULMONARY;

ANIMALS; ASTHMA; BIOMARKERS, TUMOR; CARCINOMA, NON-SMALL-CELL LUNG; CYTOKINES; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC MARKERS; HUMANS; INTERLEUKIN-10; INTERLEUKIN-12; LUNG NEOPLASMS; MICRORNAS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY TRACT DISEASES; SARCOIDOSIS, PULMONARY;

EID: 84897726803     PISSN: 08677077     EISSN: None     Source Type: Journal    
DOI: 10.5603/PiAP.2014.0024     Document Type: Article

References (53)

1. Kupczyk M., Kuna P. Epigenetyka astmy oskrzelowej. Terapia 2011; 4: 65-69.
2. Ciesla M., Skrzypek K., Kozakowska M. i wsp. MicroRNAs as biomarkers of disease onset. Annal. Bioanal. Chem. 2011; 410: 2051-2061.
3. Nakajima M., Yokoi T. MicroRNAs from biology to future pharmacotherapy: regulation of cytochrome P450s and nuclear receptors. Pharmacology and Therapeutics 2011; 131: 330-337.
4. Maes T., Tournoy K.G., Joos G.F. Gene therapy for allergic airway diseases. Curr. Allergy Asthma Rep. 2011; 11: 163-172.
5. Williams A.E., Larner-Svensson H., Perry M.M. i wsp. MicroRNA expression profiling in mild asthmatic human airways and effect of corticosteroid therapy. PLoS ONE 2011; 4: e5889. Doi: 10.1371/journal.pone.0005889.
6. Persson H., Kvist A., Rego N. i wsp. Identification of new microRNAs in paired normal and tumor breast tissues suggests a dual role for the ERBB2/Her2 gene. Cancer Res. 2011; 71: 78-86.
7. Turchonovich A., Weiz L., Langheinz A., Burwinkel B. Characterization of extracellular circulating microRNA. Nucleid Acids Res. 2011; 39: 7223-7233.
8. Mattes J., Yang M., Foster P.S. Regulation of microRNA by antagomirs: a new class of pharmacological antagonists for the specific regulation of gene function? Am. J. Respir. Cell Mol. Biol. 2007; 36: 8-12.
9. Busse W.W. Difficult-to-treat asthma: how serious is the problem and what are the issues? Eur. Respir. Mon. 2011; 51: 1-15.
10. Jiang X. The emerging role of microRNAs in asthma. Mol. Cell. Biochem. 2011; 353: 35-40.
11. Polikepahad S., Knight J.M., Naghavi A.O. i wsp. Proinflammatory role for let-7a microRNAs in experimental asthma. J. Biol. Chem. 2010; 285: 30139-30149.
12. Garbacki N., Di Valentin E., Huynh-Thu V.A. i wsp. MicroRNAs profiling in murine models of acute and chronic asthma: a relationship with mRNAs targets. PLoS ONE 2011; 6: e16509.
13. Tan Z., Randall G., Fan J. i wsp. Allelespecific targeting of microRNAs to HLA-G and risk of asthma. Am. J. Hum. Genet. 2007; 81: 829-834.
14. Williams A.E., Larner-Svensson H., Perry M.M. i wsp. MicroRNA expression profiling in mild asthmatic human airways and effect of corticosteroid therapy. PLoS ONE 2011; 4: e5889. Doi: 10.1371/journal.pone.0005889.
15. Solberg O.D., Ostrin E.J., Love M.I. i wsp. Airway epithelial miRNA expression is altered in asthma. Am. J. Respir. Crit. Care Med. 2012; 186: 965-974.
16. Jardim M.J., Dailey L., Silbajoris R. i wsp. Distinct microRNA expression in human airway cells of asthmatic donors identifies a novel asthma-associated gene. Am. J. Respir. Cell Mol. Biol 2012; 47: 536-542.
17. Levanen B., Bhakta N.R., Paredes P.T. i wsp. Altered microRNA profiles in bronchoalveolar fluid exosomes in asthmatic patients. J. Allergy Clin. Immunol. 2013; 131: 894-903.
18. Paredes P.T., Esser J., Admyre C. i wsp. Bronchoalveolar lavage fluid exosomes contribute to cytokine and leukotriene production in allergic asthma. Allergy 2012; 67: 911-919.
19. Collison A., Herbert C., Siegle J.S. i wsp. Altered expression of microRNA in the airway wall in chronic asthma: miR-126 as a potential therapeutic target. BMC Pulmonary Medicine 2011; 11: 29.
20. Collison A., Mattes J., Plank M. i wsp. Inhibition of house dust mite-induced allergic airways disease by antagonism of microRNA-145 is comparable to glucocorticoid treatment. J. Allergy Clin. Immunol. 2011; 128: 160-167.
21. Chiba Y., Misawa M. MicroRNAs and their therapeutic potential for human diseases: miR-133a and bronchial smooth muscle hyperresponsiveness in asthma. J. Pharmacol. Sci. 2010; 114: 264-268.
22. Oglesby I.K., McElvaney N., Greene C.M. MicroRNAs in inflammatory lung disease-master regulators or target practice? Respiratory Research 2010; 11: 148.
23. Takahashi K., Yokota S., Tatsumi N. i wsp. Cigarette smoking substantially alters plasma microRNA profiles in healthy subjects. Toxicol. Applied Pharmacology 2013; 272: 154-160.
24. Van Pottelberge G.R., Mestdagh P., Bracke K.R. i wsp. MicroRNA expression in induced sputum of smokers and patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2011; 183: 898-906.
25. Donaldson A., Natanek S.A., Lewis A. i wsp. Increased skeletal muscle-specific microRNA in the blood of patients with COPD. Thorax 2013; published on line 28.06.2013 doi: 10.1136
26. Soeda S., Ohyashiki J.H., Ohtsuki K. i wsp. Clinical relevance of plasma miR-106b levels in patients with chronic obstructive pulmonary disease. Int. J. Mol. Medicine 2013; 31: 533-539.
27. Akbas F., Coskunpinar E., Aynaci E. i wsp. Analysis of serum micro-RNA as potential biomarker in chronic obstructive pulmonary disease. Exp. Lung Res. 2012; 38: 286-294.
28. Pinkerton M., Chinchilli V., Banta E. i wsp. Differential expression of microRNAs in exhaled breath condensates of patients with asthma, patients with chronic obstructive pulmonary disease, and healthy adults. J. Allergy Clin. Immunol. 2013; 132: 217-219.
29. Kass D.J., Kaminski N. Evolving genomic approaches to idiopathic pulmonary fibrosis: moving beyond genes. Clin. Transl. Sci. 2011; 4: 372-379.
30. Liu G, Friggeri A, Yang Y i wsp. miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis. J Exp Med 2010; 207: 1589-1597.
31. Crouser E.D., Julian M.W., Crawford M. i wsp. Differential expression of micro RNA and predicted targets in pulmonary sarcoidosis. Biochem. Biophys. Res. Commun. 2012; 417: 886-891.
32. Calin G.A., Sevignani C., Dumitru C.D. i wsp. Human microRNAs genes are frequently located at fragile sites and genomic regions involved in cancers. Proc. Natl. Acad. Sci. USA 2004; 101: 2999-3004.
33. Nana-Sinkam S.P., Croce C.M. MicroRNAs as therapeutic targets in cancer. Transl. Res. 2011; 157: 216-225.
34. Landi M.T., Zhao Y., Rotunno M. i wsp. MicroRNA signature predicts survival and relapse in lung cancer. Cancer Cell 2008; 13: 48-57.
35. Voortman J., Goto A., Mendiboure J. i wsp. MicroRNA expression and clinical outcomes in patients treated with adjuvant chemotherapy after complete resection of non-small cell lung carcinoma. Cancer Res. 2010; 70: 8288-8298.
36. Keller A., Leidinger P., Gislefoss R. i wsp. Stable serum miRNA profiles as potential tool for non-invasive lung cancer diagnosis. RNA Biol. 2011; 8: 506-516.
37. Chen X., Hu Z., Wang W. i wsp. Identification of ten serum microRNAs from a genome-wide serum microRNA expression profile as novel non-invasive biomarkers for non-small cell lung cancer diagnosis. Int. J. Cancer 2011; 130: 1620-1628.
38. Skrzypski M., Dziadziuszko R., Jassem J. MicroRNA in lung cancer diagnostics and treatment. Mutat. Res. 2011; 717: 25-31.
39. Markou A., Sourvinou I., Vorkas P.A. i wsp. Clinical evaluation of microRNA expression profiling in non small cell lung cancer. Lung Cancer 2013; 81: 388-396.
40. Sanfiorenzo C., Ilie M.I., Belaid A. i wsp. Two panels of plasma microRNAs as non-invasive biomarkers for prediction of reccurence in resectable NSCLC. PLoS ONE 2013; 8: e54596.
41. Rani S., Gately K., Crown J. i wsp. Global analysis of serum microRNAs as potential biomarkers for lung adenocarcinoma. Cancer Biol. Ther. 2013; 14: Epub ahead of print.
42. Xu T., Liu X., Han L. i wsp. Up-regulation of miR-9 expression as a poor prognostic biomarker in patients with non-small cell lung cancer. Clin. Transl. Oncol. 2013 Sep 10 Epub ahead of print.
43. Zhang H.H., Zhang Z.Y., Che C.L. i wsp. Array analysis for potential biomarker of gemcitabine identification in non-small cell lung cancer cell lines. Int. J. Clin. Exp. Pathol. 2013; 6: 1734-1746.
44. Song L., Li Y., Wu S. i wsp. MiR-495 enhances the sensitivity of non-small cell lung cancer cells to platinum by modulation of copper-transporting P-type adenosine triphosphatase A (ATP7A). J. Cell Biochem. 2013; Sep 5 doi: 10.1002, Epub ahead of print.
45. Luo X., Burwinkel B., Tao S., Brenner H. MicroRNA signatures: new biomarker for colorectal cancer? Cancer Epidemiol. Biomarkers Prev. 2011; 20: 1272-1286.
46. Mahn R., Haukamp L.C., Rogenhofer S. i wsp. Circulationg microRNAs (miRNA) in serum of patients with prostate cancer. Urology 2011; 77: 1265. e9-1265. e16.
47. Babu J.M., Prathibha R., Jijith V.S. i wsp. A miR-centric view of head and neck cancers. Biochim. Biphys. Acta 2011; 1816: 67-72.
48. Hui A.B., Lenarduzzi M., Krushel T. i wsp. Comprehensive MicroRNA profiling for head and neck squamous cell carcinomas. Clin. Cancer Res. 2010; 16: 1129-1139.
49. Trang P., Medina P.P., Wiggins J.F. i wsp. Regression of murine lung tumors by the let-7 microRNA. Oncogene 2010; 29: 1580-1587.
50. Broderick J.A., Zamore P.D. MicroRNA therapeutic. Gene Therapy 2011; 18: 1104-1110.
51. Ellis K.L., Cameron V.A., Troughton R.W. i wsp. CirculatingmicroRNAs as candidatemarkers to distinguish heart failure in breathless patients. Eur. J. Heart Fail. 2013; doi: 10.1093, Epub ahead of print.
52. Dalal S.R., Kwon J.H. The role of microRNA in inflammatory bowel disease. Gastroenterol. Hepatol. 2010; 6: 714-722.
53. Auffrey C., Adcock I.M., Chung K.F. i wsp. An integrative systems biology approach to understanding pulmonary diseases. Chest 2010; 137: 1410-1416.